- A Potential Role of Salmonella Infection in the Onset of Inflammatory Bowel Diseases
Bárbara M. Schultz et al, 2017, Front. Immunol. CrossRef - Doxycycline, metronidazole and isotretinoin: Do they modify microRNA/mRNA expression profiles and function in murine T-cells?
Eugenia Becker et al, 2016, Sci Rep CrossRef - null
Monica I. Ardura et al, 2017 CrossRef - Associations between host gene expression, the mucosal microbiome, and clinical outcome in the pelvic pouch of patients with inflammatory bowel disease
Xochitl C Morgan et al, 2015, Genome Biol CrossRef - The involvement of gut microbiota in inflammatory bowel disease pathogenesis: Potential for therapy
Giovanni Cammarota et al, 2015, Pharmacology & Therapeutics CrossRef - Gut microbiota and IBD: causation or correlation?
Josephine Ni et al, 2017, Nat Rev Gastroenterol Hepatol CrossRef - Insights from immunology: New targets for new drugs?
Tim Raine, 2014, Best Practice & Research Clinical Gastroenterology CrossRef - IBD and the Gut Microbiota—from Bench to Personalized Medicine
Emanuelle Bellaguarda et al, 2015, Curr Gastroenterol Rep CrossRef - The Significance of the Enteric Microbiome on the Development of Childhood Disease: A Review of Prebiotic and Probiotic Therapies in Disorders of Childhood
John Slattery et al, 2016, Clinical Medicine Insights: Pediatrics CrossRef - Role of antibiotics for treatment of inflammatory bowel disease
Orna Nitzan, 2016, WJG CrossRef - Review article: the gut microbiome in inflammatory bowel disease-avenues for microbial management
J. McIlroy et al, 2017, Aliment Pharmacol Ther CrossRef - PCR detection of segmented filamentous bacteria in the terminal ileum of patients with ulcerative colitis
Alessia Finotti et al, 2017, BMJ Open Gastroenterol CrossRef - Microbiota in Inflammatory Bowel Disease Pathogenesis and Therapy
Daniela Elena Serban, 2015, Nutr Clin Pract CrossRef - Helminth therapy (worms) for induction of remission in inflammatory bowel disease
Sushil K Garg et al, 2014 CrossRef - Perturbation of the Human Microbiome as a Contributor to Inflammatory Bowel Disease
Bayan Missaghi et al, 2014, Pathogens CrossRef - Evidence-based clinical practice guidelines for inflammatory bowel disease
Katsuyoshi Matsuoka et al, 2018, J Gastroenterol CrossRef - Life-long antimicrobial therapy: where is the evidence?
Jillian S Y Lau et al, 2018 CrossRef - null
Wayne Young et al, 2018 CrossRef - Can inflammatory bowel disease be permanently treated with short-term interventions on the microbiome?
Dana Berg et al, 2015, Expert Review of Gastroenterology & Hepatology CrossRef - Management of Paediatric Ulcerative Colitis, Part 2
Dan Turner et al, 2018, Journal of Pediatric Gastroenterology and Nutrition CrossRef - Management of Paediatric Ulcerative Colitis, Part 1
Dan Turner et al, 2018, Journal of Pediatric Gastroenterology and Nutrition CrossRef - The Microbiome in Inflammatory Bowel Disease: From Prevailing Clinical Evidence to Future Possibilities
Hari K. Somineni et al, 2018, Clinical Gastroenterology and Hepatology CrossRef - Management of Ulcerative Colitis in the Elderly
Manish P. Shrestha et al, 2018, Drugs Aging CrossRef - null
Janett Nörenberg et al, 2019 CrossRef - Secretion of Alpha-Hemolysin by Escherichia coli Disrupts Tight Junctions in Ulcerative Colitis Patients
Hengameh Chloé Mirsepasi-Lauridsen et al, 2016, Clinical and Translational Gastroenterology CrossRef - Efficacy of Combination Antibiotic Therapy for Refractory Pediatric Inflammatory Bowel Disease
Jessica Breton et al, 2019 CrossRef - Induction and maintenance treatment of inflammatory bowel disease: A comprehensive review
Dong Yeon Jeong et al, 2019, Autoimmunity Reviews CrossRef - The microbiome, cancer, and cancer therapy
Beth A. Helmink et al, 2019, Nat Med CrossRef - Gut microbiome composition and function in experimental colitis during active disease and treatment-induced remission
Michelle G Rooks et al, 2014, ISME J CrossRef - Acute severe ulcerative colitis: from pathophysiology to clinical management
Pieter Hindryckx et al, 2016, Nat Rev Gastroenterol Hepatol CrossRef - Carcinoembryonic antigen (CEACAM) family members and Inflammatory Bowel Disease
Maebh Kelleher et al, 2019, Cytokine & Growth Factor Reviews CrossRef - Dysregulation of Intestinal Epithelial Cell RIPK Pathways Promotes Chronic Inflammation in the IBD Gut
Ricard Garcia-Carbonell et al, 2019, Front. Immunol. CrossRef - Microbial biofilms and gastrointestinal diseases
Erik C. von Rosenvinge et al, 2013, Pathogens Disease CrossRef - null
Chaorui Tian et al, 2013 CrossRef - Ciprofloxacin Usage and Bacterial Resistance Patterns in Crohn’s Disease Patients With Abscesses
Soo-Kyung Park et al, 2014, Journal of Clinical Gastroenterology CrossRef - Current overview of extrinsic and intrinsic factors in etiology and progression of inflammatory bowel diseases
Marta Sobczak et al, 2014, Pharmacological Reports CrossRef - Commentary: adjunct antibiotic combination therapy for ulcerative colitis - is it time to investigateFusobacterium varium?
G. Fiorino et al, 2014, Aliment Pharmacol Ther CrossRef - Combination of oral antibiotics may be effective in severe pediatric ulcerative colitis: A preliminary report
Dan Turner et al, 2014, Journal of Crohn's and Colitis CrossRef - First Case Report of De Novo Ulcerative Colitis Developing After Orthotopic Liver Transplantation Successfully Treated by Granulocyte and Monocyte Apheresis
S. Ihara et al, 2014, Transplantation Proceedings CrossRef - Gut Microbiota and Inflammatory Bowel Disease: The Role of Antibiotics in Disease Management
David H. Kerman et al, 2014, Postgraduate Medicine CrossRef - Use of antibiotics in patients with Crohn's disease: A systematic review and meta-analysis
Jie Wen Su et al, 2015, Journal of Digestive Diseases CrossRef - Therapeutic Manipulation of the Microbiome in IBD: Current Results and Future Approaches
Jonathan J. Hansen et al, 2015, Curr Treat Options Gastro CrossRef - A new therapeutic association to manage relapsing experimental colitis: Doxycycline plus Saccharomyces boulardii
José Garrido-Mesa et al, 2015, Pharmacological Research CrossRef - Controlled delivery of a new broad spectrum antibacterial agent against colitis: In vitro and in vivo performance
M.S. Nieto-Bobadilla et al, 2015, European Journal of Pharmaceutics and Biopharmaceutics CrossRef - Adjuvant use of antibiotics with corticosteroids in inflammatory bowel disease exacerbations requiring hospitalisation: a retrospective cohort study and meta-analysis
V. Gupta et al, 2016, Aliment Pharmacol Ther CrossRef - Review article: the potential mechanisms of action of rifaximin in the management of inflammatory bowel diseases
R. B. Sartor, 2016, Aliment Pharmacol Ther CrossRef - Antibiotics as deep modulators of gut microbiota: between good and evil
Gianluca Ianiro et al, 2016, Gut CrossRef - null
Ralph Francescone et al, 2016 CrossRef - Advances in Gut Microbiome Research and Relevance to Pediatric Diseases
Lindsey Albenberg et al, 2016, The Journal of Pediatrics CrossRef - Therapeutic modulation of gut microbiota in inflammatory bowel disease: More questions to be answered
Yu Qi Qiao et al, 2016, Journal of Digestive Diseases CrossRef - Pediatric Inflammatory Bowel Disease
Máire A. Conrad et al, 2017, Pediatric Clinics of North America CrossRef - The role of the gut microbiota in the treatment of inflammatory bowel diseases
Ioanna Aggeletopoulou et al, 2019, Microbial Pathogenesis CrossRef - Microbial-Based and Microbial-Targeted Therapies for Inflammatory Bowel Diseases
Akihiko Oka et al, 2020, Dig Dis Sci CrossRef - Host–microbiota interactions in inflammatory bowel disease
Roberta Caruso et al, 2020, Nat Rev Immunol CrossRef - null
Klaus-Michael Keller, 2020 CrossRef - Double‐blind, randomised, placebo‐controlled crossover trial to evaluate the clinical efficacy of rifaximin in patients with moderate to severe active Crohn’s disease
Scott D. Lee et al, 2020, GastroHep CrossRef - IBDs and the pediatric age: Their peculiarities and the involvement of the microbiota
Lucia Cococcioni et al, 2020, Digestive and Liver Disease CrossRef - Effect of antibiotic therapy in patients with ulcerative colitis: a meta-analysis of randomized controlled trials
Wenjie Xi et al, 2020, Scandinavian Journal of Gastroenterology CrossRef - Impact of Microbial Metabolites on Microbiota–Gut–Brain Axis in Inflammatory Bowel Disease
Davide Banfi et al, 2021, IJMS CrossRef - null
Samuel Bitton et al, 2021 CrossRef - Modulation of the Gut Microbiota-farnesoid X Receptor Axis Improves Deoxycholic Acid-induced Intestinal Inflammation in Mice
Mengque Xu et al, 2021 CrossRef - null
Legaki Evangelia et al, 2021 CrossRef - WSES-AAST guidelines: management of inflammatory bowel disease in the emergency setting
Belinda De Simone et al, 2021, World J Emerg Surg CrossRef - Intestinal Microbiota in Common Chronic Inflammatory Disorders Affecting Children
Anna Torun et al, 2021, Front. Immunol. CrossRef - Antibiotics in pediatric Inflammatory Bowel Diseases: a systematic review
Charlotte M. Verburgt et al, 2021, Expert Review of Gastroenterology & Hepatology CrossRef - Outcomes of Immune Checkpoint Inhibitor–related Diarrhea or Colitis in Cancer Patients With Superimposed Gastrointestinal Infections
Weijie Ma et al, 2021 CrossRef - Micro- and nanotechnological delivery platforms for treatment of dysbiosis-related inflammatory bowel disease
Dingpei Long et al, 2021, Nanomedicine CrossRef - null
Catiele Antunes et al, 2021 CrossRef - Inflammatory bowel disease: The role of commensal microbiome in immune regulation
Martín Ivan Wah-Suárez et al, 2021, Gastroenterología y Hepatología CrossRef - Oral nanomedicine for modulating immunity, intestinal barrier functions, and gut microbiome
Yonghyun Lee et al, 2021, Advanced Drug Delivery Reviews CrossRef - Naringin Exhibited Therapeutic Effects against DSS-Induced Mice Ulcerative Colitis in Intestinal Barrier–Dependent Manner
Ruige Cao et al, 2021, Molecules CrossRef - Emerging Pharmacotherapy for Inflammatory Bowel Diseases
Hua Luo et al, 2022, Pharmacological Research CrossRef - Identification of gut microbiome and transcriptome changes in ulcerative colitis and pouchitis
Xin Gao et al, 2022, Scandinavian Journal of Gastroenterology CrossRef - Abdominal Abscess in Crohn's Disease: Multidisciplinary Management
E. Joline de Groof et al, 2014, Dig Dis CrossRef - Gastrointestinal dysbiosis and Escherichia coli pathobionts in inflammatory bowel diseases.
Andreas Munk Petersen, 2022, APMIS CrossRef - The Role of the Human Gut Microbiome in Inflammatory Bowel Disease and Radiation Enteropathy
Darren Fernandes et al, 2022, Microorganisms CrossRef - A 7-Year-Old With Persistent Fever and Cough
Ethan S. Vorel et al, 2022 CrossRef - Inflammatory bowel disease: The role of commensal microbiome in immune regulation
Martín Ivan Wah-Suárez et al, 2022, Gastroenterología y Hepatología (English Edition) CrossRef - Investigating dysbiosis and microbial treatment strategies in inflammatory bowel disease based on two modified Koch’s postulates
HanZheng Zhao et al, 2022, Front. Med. CrossRef - Treatment of Crohn's disease
Petr BARTOŠKA et al, 2022, Gazz Med Ital - Arch Sci Med CrossRef - null
Monica I. Ardura et al, 2023 CrossRef - null
Jessica Breton et al, 2023 CrossRef - In inflammatory bowel disease and extraintestinal manifestations: what role does microbiome play?
Yong-Hua Shen et al, 2023, Engineered Regeneration CrossRef - null
Jyoti Sharma et al, 2023 CrossRef - Metronidazole Attenuates the Intensity of Inflammation in Experimental Autoimmune Uveitis
P. Seidler Stangova et al, 2019, Fol. Biol. CrossRef - High prevalence of Mucosa-Associated extended-spectrum β-Lactamase-producing Escherichia coli and Klebsiella pneumoniae among Iranain patients with inflammatory bowel disease (IBD)
Ayda Afshari Kharaghani et al, 2023, Ann Clin Microbiol Antimicrob CrossRef -
Pathogens in Crohn's Disease: The Role of Adherent Invasive Escherichia coli
Gaetano Iaquinto et al, 2024, Crit Rev Eukaryot Gene Expr CrossRef - Antibiotic Therapy for Active Crohn’s Disease Targeting Pathogens: An Overview and Update
Gaetano Iaquinto et al, 2024, Antibiotics CrossRef - Composition and Pathogenic Potential of Mucosal Microbiota in Ulcerative Colitis
S. A. Tsvetikova et al, 2024, Russ J Bioorg Chem CrossRef